Biogen Inc (NASDAQ:BIIB) over-valued by 11%
| Website | https://www.biogen.com/ |
| Sector | Healthcare |
| Industry | Drug Manufacturers General |
| Fiscal Year End | Dec 31, 2019 |
| Market Cap | $54,725,054,000 |
| Beta | 0.56693 |
| Average Volume | $1,194,749 |
| Last Dividend | 0% |
| Price on Jul 22, 2020 | $355.63 |
| Autochartist™ Valuation | $316.45 |
| Conclusion |
11% over-valued |
| Download Report |
